All lobbying filings

BANNER PUBLIC AFFAIRS, LLC

Lobbying for THE CIGNA GROUP AND SUBSIDIARIES (FKA CIGNA CORPORATION AND SUBSIDIARIES) · Health Care Services

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $20,000.00 income · posted Apr 21, 2025

Official filing document

Bills named in this filing 9

HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025
S 526
Pharmacy Benefit Manager Transparency Act of 2025
S 1339
Pharmacy Benefit Manager Reform Act
S 1542
DRUG Act
HR 2214
DRUG Act
S 1038
Drug Price Transparency in Medicaid Act of 2023
HR 1613
Drug Price Transparency in Medicaid Act of 2023
HR 10362
PBM Act of 2024
S 5503
PBM Act

Lobbying activity 2

Defense

Pharmacy issues related to TRICARE; National Defense Authorization Act for FY2026; H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025; Department of Defense Appropriations, FY2026.

Health Issues

S.526 - Pharmacy Benefit Manager Transparency Act of 2025; S. 1339 - Pharmacy Benefit Reform Act (118th Congress); S. 1542/H.R. 2214 - DRUG Act (118th Congress); S. 1038/H.R. 1613 - Drug Price Transparency in Medicaid Act of 2023 (118th Congress); S. 5503/H.R. 10362 - PBM Act of 2024 (118th Congress).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.